1. Home
  2. Labeler Index
  3. Cipla Usa Inc.
  4. 69097-532
  5. NDC Package Code: 69097-532-32 Sodium Nitroprusside

NDC Package 69097-532-32 Sodium Nitroprusside

Injection, Solution, Concentrate Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
69097-532-32
Package Description:
1 VIAL, SINGLE-DOSE in 1 CARTON / 2 mL in 1 VIAL, SINGLE-DOSE
Product Code:
69097-532
Proprietary Name:
Sodium Nitroprusside
Non-Proprietary Name:
Sodium Nitroprusside
Substance Name:
Sodium Nitroprusside
Usage Information:
Sodium nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. Concomitant longer-acting antihypertensive medication should be administered so that the duration of treatment with sodium nitroprusside can be minimized.Sodium nitroprusside is also indicated for producing controlled hypotension in order to reduce bleeding during surgery.Sodium nitroprusside is also indicated for the treatment of acute congestive heart failure.
11-Digit NDC Billing Format:
69097053232
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Cipla Usa Inc.
Dosage Form:
Injection, Solution, Concentrate - A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections.
Administration Route(s):
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s):
SODIUM NITROPRUSSIDE 50 mg/2mL
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
ANDA210855
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
07-16-2018
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 69097-532-32?

The NDC Packaged Code 69097-532-32 is assigned to a package of 1 vial, single-dose in 1 carton / 2 ml in 1 vial, single-dose of Sodium Nitroprusside, a human prescription drug labeled by Cipla Usa Inc.. The product's dosage form is injection, solution, concentrate and is administered via intravenous form.

Is NDC 69097-532 included in the NDC Directory?

Yes, Sodium Nitroprusside with product code 69097-532 is active and included in the NDC Directory. The product was first marketed by Cipla Usa Inc. on July 16, 2018 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 69097-532-32?

The 11-digit format is 69097053232. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-269097-532-325-4-269097-0532-32